A Single Testing of Serum Amyloid A Levels as a Tool for Diagnosis and Treatment Dilemmas in Familial Mediterranean Fever

Sohar, 1967, Familial Mediterranean fever, Am J Med, 43, 227, 10.1016/0002-9343(67)90167-2 Livneh, 1996, The changing face of familial Mediterranean fever, Semin Arthritis Rheum, 26, 612, 10.1016/S0049-0172(96)80012-6 Liepnieks, 1995, Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid A1, Biochim Biophys Acta, 1270, 81, 10.1016/0925-4439(94)00076-3 Merlini, 2003, Molecular mechanisms of amyloidosis, N Engl J Med, 349, 583, 10.1056/NEJMra023144 Cunnane, 2001, Amyloid precursors and amyloidosis in inflammatory arthritis, Curr Opin Rheumatol, 13, 67, 10.1097/00002281-200101000-00011 Tunca, 1999, Acute phase response and evolution of familial Mediterranean fever, Lancet, 353, 1415, 10.1016/S0140-6736(99)00990-3 Duzova, 2003, Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever, Clin Exp Rheumatol, 21, 509 Korkmaz, 2002, Acute phase response in familial Mediterranean fever, Ann Rheum Dis, 61, 79, 10.1136/ard.61.1.79 Gillmore, 2001, Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein, Lancet, 358, 24, 10.1016/S0140-6736(00)05252-1 Lachmann, 2006, Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations, Rheumatology (Oxford), 45, 746, 10.1093/rheumatology/kei279 Zemer, 1986, Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever, N Engl J Med, 314, 1001, 10.1056/NEJM198604173141601 Livneh, 1997, Criteria for the diagnosis of familial Mediterranean fever, Arthritis Rheum, 40, 1879, 10.1002/art.1780401023 Zaks, 2003, Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever, Isr Med Assoc J, 5, 585 Padeh, 2003, Clinical and diagnostic value of genetic testing in 216 Israeli children with familial Mediterranean fever, J Rheumatol, 30, 185 Livneh, 1999, MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever, Amyloid, 6, 1, 10.3109/13506129908993281 Cazeneuve, 1999, MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications, Am J Hum Genet, 65, 88, 10.1086/302459 Tunca, 2005, Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study, Medicine (Baltimore), 84, 1, 10.1097/01.md.0000152370.84628.0c Livneh, 2000, Diagnostic and treatment concerns in familial Mediterranean fever, Baillieres Best Pract Res Clin Rheumatol, 14, 477, 10.1053/berh.2000.0089 Kogan, 2001, Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state, Am J Med Genet, 102, 272, 10.1002/ajmg.1438 Gershoni-Baruch, 2003, The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever, Arthritis Rheum, 48, 1149, 10.1002/art.10944 Gershoni-Baruch, 2003, Male sex coupled with articular manifestations cause a 4-fold increase in susceptibility to amyloidosis in patients with familial Mediterranean fever homozygous for the M694V-MEFV mutation, J Rheumatol, 30, 308